This week on The Rounds Table Kieran is joined by Dr. Dan Aronov, a new voice on The Rounds Table from Melbourne, Australia. Kieran and Dan guide listeners through recent advances in cardiovascular care.
Dan steers listeners through the COMPASS trial examining rivaroxaban with or without aspirin in patients with stable atherosclerotic vascular disease to prevent recurrent cardiovascular events. Next, Kieran covers an innovative cluster RCT of a pharmacist led intervention in which antihypertensive care was delivered to black males while attending barbershops.
Finally the Good Stuff segment. Dan shares a trial on drug approval with limited evidence. Kieran shares a story on digital therapeutics: mobile apps prescribed by physicians.
If you like what you hear, rate us on iTunes! Chat with us on Twitter @roundstable and tweet at Kieran @kieranlquinn, and Dan @DrAronov. Let us know how we’re doing here: https://www.surveymonkey.com/r/3P59S9G.
2. Barbershop BP: https://www.nejm.org/doi/pdf/10.1056/NEJMoa1717250
1. Limited Evidence: https://www.bmj.com/content/357/bmj.j1680
2. Digital Therapeutics: https://www.nytimes.com/2018/03/18/technology/take-this-app-and-call-me-in-the-morning.html
The Rounds Table Theme Music by Brendan Quinn, Creative Director and Composer, Vapor RMW